Define smoking cessation assistance. smoking cessation assistance synonyms, smoking cessation assistance pronunciation, smoking cessation assistance translation, English dictionary definition of smoking cessation assistance. n. 1. The act of assisting. 2. Aid; help: financial assistance. n 1. help; support 2. the act of assisting 3. informal Brit See national assistance n.

The European Smoking Cessation Guidelines and Quality Standards are the main output of a project undertaken by ENSP to create a coherent and reliable set of guidelines for healthcare professionals working in the field of smoking cessation. The Guidelines form a complete range of tools to support smoking cessation strategies. The work was undertaken by the Editorial Board comprising seven eminent professors and the Board of Revisers from across the entire European continent and is the first of its kind. These guidelines are in accordance with Article 14 of the Framework Convention on Tobacco Control (FCTC), which states that:. Parties should develop and disseminate comprehensive tobacco dependence treatment guidelines based on the best available scientific evidence and best practices, taking into account national circumstances and priorities. These guidelines should include two major components: (1) a national cessation strategy, to promote tobacco cessation and provide tobacco dependence ...

ENSP is a fervent supporter of strong smoking cessation activities as a means to combat smoking prevalence. ENSP encourages the implementation of WHO FCTC Article 14 on Provision of support for reducing tobacco dependence and cessation. As the Guidelines for Implementing Article 14 state, it is encouraged to create a sustainable infrastructure which motivates attempts to quit, to identify the key, effective measures needed to promote tobacco cessation and incorporate tobacco dependence treatment into national tobacco control programmes and finally for national states to share experiences and collaborate in order to facilitate the development or strengthening of support for tobacco cessation and tobacco dependence treatment.. Read more in the ENSP Smoking Cessation Guidelines available in various languages and about the project treating smoking cessation:. ...

The 1996 guideline, Smoking Cessation, Clinical Practice Guideline, No. 18, sponsored by the Agency for Health Care Policy and Research, has been superseded by a new, updated Tobacco Cessation Guideline released by the Public Health Service in 2008.. The information and treatment recommendations provided in the earlier Smoking Cessation Guideline products listed below are out of date. These products have been removed from the Health Services/Technology Assessment Text (HSTAT), an electronic system maintained by the National Library of Medicine.. ...

The aim of this study is to assess the effects of N-acetylcysteine (NAC) on initial cessation and relapse prevention in adult cigarette smokers. Specifically, this study has the following aims: Aim 1) Examine the efficacy of NAC, compared to placebo, in helping smokers achieve three days of continuous abstinence; Aim 2) Among those who maintain initial 3-day abstinence, examine the time to relapse over the 8-week intervention between NAC and placebo groups; Aim 3) Assess 7-day point prevalence abstinence at the 8-week end-of-treatment study visit in order to obtain effect sizes and estimates of variability to power a randomized clinical trial ...

This project will be a randomized clinical trial testing the efficacy of an internet-administered smoking cessation treatment for overweight and obese smokers. Research on internet-administered behavioral treatments for smoking cessation has found that compared to control treatments (e.g., self-help materials), cessation rates in internet-administered treatments are significantly higher. Research testing the applicability of these treatments to overweight and obese individuals has not yet been conducted. Given that a substantial portion of smokers are also overweight and at elevated cardiovascular risk, there is a need for directed treatment efforts for this group. The current trial proposes to be the first to test the effectiveness of internet-administered smoking cessation treatment for overweight and obese (BMI≥25) smokers. Adult participants will be randomized to receive 12 weeks of internet-administered treatment consisting of either: a) standard smoking cessation treatment with general ...

Coltsfoot helps soothe inflamed lung tissue, loosen secretions, and tones the lungs. The American Journal of Medicine (AJM) reports the findings of a review that observed 14 previous clinical trials who used acupuncture as an alternative therapy for smokers to kick the habit. The results of the trial showed that there was no significant difference in abstinence rates between the what tea helps to lose weight groups during weeks 9-12, although they did observe that 7-day point prevalence abstinence at week 4 of the fresh lime users was statistically significant lower than those using nicotine gum (38. Withdrawal symptoms are worse within the first week of quitting and the intensity natural remedy to quit smoking of the symptoms drops over the first month says The National Cancer Institute (NCI). Common triggers that boost your nicotine cravings can be starting the day, drinking coffee or tea and feeling stressed. Through guided meditation, visualization, relaxing music and deep breathing this ...

Most smokers become nicotine dependent and, when they stop smoking, experience withdrawal symptoms and craving. Nicotine replacement therapy (NRT) reduces these unpleasant symptoms and, theoretically, should decrease the risk of relapse. Smoking cessation is properly defined as validated sustained abstinence from cigarettes and/or other tobacco products for at least 6 months, but preferably for 1 year. This editorial includes evidence only from those studies which have applied such a definition and which have specified their settings and populations.. NRT is available as chewing gum, transdermal patches, sublingual tablets, lozenges, inhalation cartridges and nasal spray. In specialised cessation clinics1-8 and in primary care,9,10 prospective randomised clinical trials have shown that NRT, used as an adjunct to advice and support, results in better cessation rates than does advice and support alone. In the clinics success rates with NRT tend to be higher (11-30%) and more consistent than in ...

This study described smoking cessation programmes that use TKM interventions in South Korea, and the study results provide basic information for planning future smoking cessation programmes to contribute increasing smoking cessation rates and finally promoting health. In conventional western medicine, there are smoking cessation treatment guidelines for primary care physicians that were developed by the Korean Academy of Family Medicine [21]. The guidelines recommend following doctors advice, individual or group behavioural counselling, self-help interventions, attending smoking cessation clinics, and medicinal treatments, such as bupropion, nortriptyline, and NRT.. In China, a non-smoking clinic was established in 2007 at the Acupuncture and Moxibustion Hospital, Academy of Chinese Medical Sciences, and the patients were treated with acupuncture, massages, and herbal patches [22]. Traditional Chinese medicine (TCM) is relatively well used in cessation treatment; however, there are no national ...

SMOKING IS THE LEADING PREVENTABLE CAUSE OF DEATH IN THE UNITED STATES. IT IS A MAJOR CAUSE OF CANCER AND OTHER SERIOUS DISEASE, AND IS BY FAR THE LEADING CAUSE OF LUNG CANCER. THE STUDY WILL TEST A STATE-OF-THE-ART CORPORATE SMOKING CESSATION CLINIC SUPPLEMENTED BY EITHER ACTIVE OR PLACEBO NICOTINE REPLACEMENT (TRANSDERMAL NICOTINE SYSTEM). IT IS HYPOTHESIZED THAT ACTIVE NICOTINE REPLACEMENT WILL LEAD TO A SIGNIFICANT REDUCTION IN WITHDRAWAL SYMPTOMS AND TO IMPROVED ABSTINENCE. A MINIMUM OF 120 SUBJECTS FROM SIX COMPANIES WILL BE RANDOMLY ASSIGNED TO EITHER ACTIVE OR PLACEBO TRANSDERMAL PATCH. ALL SUBJECTS WILL ATTEND A 9 WEEK SMOKING CESSATION CLINIC FOLLOWED BY SEVERAL ASSESSMENT SESSIONS. WITHDRAWAL SYMPTOM AND SMOKING STATUS DATA WILL BE COLLECTED AT EACH SESSION. SELF-REPORTED ABSTINENCE WILL BE VALIDATED BY EXPIRED CARBON MONOXIDE AND SALIVA COTININE. TWELVE MONTH OUTCOME DATA WILL BE COLLECTED INDEPENDENTLY OF SBIR FUNDING. IF RESULTS ARE AS HYPOTHESIZED, A WIDELY DISSEMINABLE CORPORATE ...

This meta-analysis by Rice and Stead provides a review of smoking cessation interventions delivered by nurses to patients in hospital and outpatient settings. The findings lend support for smoking cessation counselling by nurses but provide little direction for choosing the optimal set of strategies for a smoking cessation programme (eg, self help manuals, individual counselling, or telephone follow up).. The authors classified cessation strategies into low and high intensity interventions based primarily on the duration of the intervention. Surprisingly, they observed that low intensity rather than high intensity smoking cessation strategies led to successful cessation. A review of the high intensity interventions indicates that many of them required ,1 visit by a patient to a healthcare setting (eg, multiple sessions over time) or involved group interventions. It is not possible to determine whether these factors produced the differential effect of high versus low intensity interventions. ...

Although it is well understood that tobacco smoking profoundly impacts lung cancer risk, data are limited about the extent to which smoking cessation prior to diagnosis affects overall survival and lung cancer-specific survival. Lung cancer screening offers a teachable moment, but there is uncertainty about the nature of smoking cessation benefits after a lifetime of smoking. Researchers used the International Lung Cancer Consortium (ILCC) database to learn whether smoking cessation prior to lung cancer diagnosis is associated with better overall survival and lung cancer-specific survival, considering time since smoking cessation.. Analysis was performed using data from 17 ILCC studies with available time since smoking cessation to estimate survival. Of 35,428 patients in the database, 41% were current smokers, 41% were ex-smokers, and 18% were never smokers at the time of diagnosis with lung cancer. Ex-smokers and never smokers had improved overall survival compared with current smokers ...

The strategy for the original guidelines was to rely on meta-analyses which combined the results of several (and, in some cases, a large number of) studies to arrive at a single estimate of efficacy of a specific type of intervention-for example, brief GP advice. Two key sets of meta-analyses were used: those from the Cochrane Collaboration, and those included in the smoking cessation guideline published by the Agency for Health Care Policy Research (AHCPR; now called the Agency for Healthcare Research Quality (AHRQ)).11 The advantage of this approach is that it systematically combines evidence from different trials. The disadvantages are that it does not allow for new studies that have not yet made their way into the reviews; it can mask important distinctions between interventions which are all classed as the same; it does not permit statements about interventions that have not been subject to systematic reviews; and the studies come largely from populations (primarily the US) that may be ...

Cessation Resources. Out of respect for others and the environment, the College of Staten Island is a 100% Tobacco-Free Campus.. In recognition of the fact that smoking is an addictive habit and that persons who wish to quit smoking often need support, resources to assist with smoking cessation are provided to all members of the college community to assist with their individual goals.. Resources and program descriptions are as follows:. Health & Wellness Services ...

The UK is a global leader in stop-smoking support-providing free behavioral support and cessation medication via stop smoking services (SSS) without charge to smokers. This study aimed to explore the client and service characteristics associated with abstinence 52 weeks after quitting. A prospective cohort study of 3057 SSS clients in nine different areas of England who began their quit attempt between March 2012 and March 2013 was conducted. Important determinants of long-term quitting were assessed through quit rates and multivariable logistic regression. Our results showed that the overall weighted carbon monoxide validated quit rate for clients at 52 weeks was 7.7% (95% confidence interval (CI) 6.6-9.0). The clients of advisors, whose main role was providing stop-smoking support, were more likely to quit long-term than advisors who had a generalist role in pharmacies or general practices (odds ratio (OR) 2.3 (95% CI 1.2-4.6)). Clients were more likely to achieve abstinence through group support than

10 cig/d 21 mg/qd x 6 weeks 14 mg/qd x 2 weeks WV 6. Smoking cessation pharmacotherapy should be used with a comprehensive behavioral smoking cessation program. Smoking Cessation: Fast Facts. Related MMWRs (Morbidity and Mortality Weekly Reports) State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2008-2018 February 13, 2020 / Vol. Over-the-counter products are not covered. health equity regarding smoking cessation services. Any of these products can help reduce nicotine cravings and withdrawal symptoms - making it more likely that youll stop smoking for good. Temporary abstinence Smokers who need NRT to manage the symptoms of nicotine withdrawal for the duration of the admission, but do not wish to quit smoking. Build on relationships in the community to create meaningful partnerships in governance and oversight of health equity. Currently, 80% of adult smokers smoke 10 or fewer cigarettes a day, half being non-daily smokers. The ...

Smoking is a major risk factor for a range of diseases, and quitting smoking provides considerable benefits to health. It therefore follows that clinical guidelines on disease management, particularly for diseases caused by smoking, should include smoking cessation. The aim of this study was to determine the extent to which this is the case. We conducted a systematic review investigating clinical guidelines and recommendations issued by UK national or European transnational medical speciality associations and societies issued between 2000 and 2012 on a range of diseases caused by smoking. We then investigated whether selected guidelines contained reference to smoking cessation and smoking cessation advice. Although the extent to which smoking and smoking cessation was mentioned in the guidelines varied between diseases, only 60% of guidelines identified recognised that smoking is a risk factor for the development of the disease and 40% recommended smoking cessation. Only 19% of guidelines ...

This review was conducted with the aim of exploring the effect of preoperative smoking cessation on the risk of postoperative complications, and to identify the period of cessation needed to have a beneficial effect on improving surgical outcome.. The methodological quality of studies was often limited with essential information on follow-up duration, period of smoking cessation, the control of confounding factors and the outcome assessor being blind to exposure status often missing. Only three studies validated smoking cessation status and therefore some patients may have reported being abstinent from smoking but may have been smoking, as revealed by one study that did validate smoking cessation status.17 There were also significant differences between the sample characteristics and medical procedures in the groups of current smokers, past smokers and non-smokers which may limit the comparisons that can be made between the groups. For example, some aspects of surgical procedures such as wedge ...

© 2015 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. Aims: Financial incentives were the single most effective intervention for smoking cessation in pregnancy in a recent Cochrane Review, but based on a few small trials in the United States using only 7-day point prevalence measures of cessation. This study estimates (a) prolonged cessation in an unselected population of English pregnant smokers who are offered financial incentives for quitting and (b) gaming, i.e.false reporting of smoking status to enter the scheme or gain an incentive. Design: Single-arm intervention study Setting: Antenatal clinic and community Participants: A total of 239 pregnant smokers enrolled into the financial incentive scheme, attending for maternity care at one hospital in an area of high deprivation in England over a 42-week period. Measurements: Smoking cessation at delivery and 6months postpartum, assessed using salivary cotinine; gaming assessed using

All study participants were also made to realize the harmful effects of tobacco smoking and smoking cessation clinics were integrated with the lung cancer screening programme, shared Dr Triphuridet. As per the WHO Report on the Global Tobacco Epidemic 2015, at present 19.9 percent of adults in Thailand are tobacco smokers (39 percent males and 2.1 percent females). There is data that shows a strong linkage between smoking cessation rate and cost-effectiveness of CT screening. For example, at the smoking cessation rate of 3 percent, the annual screening for smokers aged 50-74 years (with 40-pack years) costs $110,000-$166,000/QALY (quality-adjusted life-years gained). But, if the cessation rate is doubled the cost is reduced to ,$75,000/QALY. If quit rates are halved, benefits from screening are almost wiped out. Thus, integration of smoking cessation practices into lung cancer screening programmes is an important step in improving the cost-effectiveness of screening ...

Exercise has received attention as a method to prevent or reduce post cessation weight gain. However, little is known about how weight changes following quit attempts contribute to the relationship between exercise and smoking cessation. The present study assessed how exercise relates to cessation and whether initial changes in exercise after quitting smoking promote cessation through attenuated weight gain. Weight-concerned women smokers (N = 342) receiving cessation treatment provided biochemical validation of cessation, reported weekly exercise activities, and were weighed at 1, 3, and 6 months following treatment initiation. Survival analyses were used to determine time to and risk of relapse among women who reported engaging in varied levels of exercise at baseline. A mediation analysis was used to examine whether the effect of initial changes in exercise on longer-term cessation was driven by change in weight. All analyses were adjusted for relevant covariates. ...

2010) Trial protocol and preliminary results for a cluster randomised trial of behavioural support versus brief advice for smoking cessation in adolescents. BMC Research Notes, Vol.3 (No.336 ...

RATIONALE: Using nicotine replacement therapy (NRT) whilst smoking, prior to quitting, is called preloading. Two reviews have estimated the effect of preloading on abstinence, but need updating. Neither investigated possible mediators or moderators of the effect, which could have implications for individual treatment plans. OBJECTIVES: To update the nicotine preloading efficacy estimate and test four hypotheses: (1) Efficacy is mediated through reduced smoking reward, (2) efficacy is mediated through increased NRT adherence post-quit, (3) efficacy is mediated through increased confidence, and (4) behavioural support modifies efficacy. METHODS: Randomised controlled trials were included that allocated cigarette smokers attempting to quit to either a preloading or control condition. A Mantel-Haenszel fixed-effect model was used to calculate risk ratios from quit rates at short- and long-term follow-ups. We carried out sub-group analyses and synthesised the data available on possible mediators and

National Standard for Tobacco Cessation Support Programme STANDARDS DOCUMENT The development of a National Standard for Intensive Tobacco Cessation Support Services is one of the key priorities of the

Smoking cessation (also known as quitting smoking) is the process of discontinuing tobacco smoking. Tobacco smoke contains nicotine, which is addictive. Nicotine withdrawal makes the process of quitting often very prolonged and difficult. Seventy percent of smokers would like to quit smoking, and 50 percent report attempting to quit within the past year. Smoking is the leading preventable cause of death worldwide. Tobacco cessation significantly reduces the risk of dying from tobacco-related diseases such as coronary heart disease, chronic obstructive pulmonary disease (COPD), and lung cancer. Due to its link to many chronic diseases, cigarette smoking has been restricted in many public areas. Many different strategies can be used for smoking cessation, including quitting without assistance (cold turkey or cut down then quit), behavioral counseling, and medications such as bupropion, cytisine, nicotine replacement therapy, or varenicline. Most smokers who try to quit do so without assistance, ...

Smoking Cessation Resources for Patients One of the best things that you can do for your health is to quit smoking. According to the Centers for Disease Control (CDC), these are the benefits you can gain from quitting your tobacco habit: Lowered risk for lung cancer and many other types of cancer. Reduced risk for […]

Cigarette smoking causes significant morbidity and mortality in the United States. Physicians can use the five As framework (ask, advise, assess, assist, arrange) to promote smoking cessation. All patients should be asked about tobacco use and assessed for motivation to quit at every clinical encounter. Physicians should strongly advise patients to quit smoking, and use motivational interviewing techniques for patients who are not yet willing to stop smoking. Clinical contacts with unmotivated patients should emphasize the rewards and relevance of quitting, as well as the risks of smoking and anticipated barriers to abstinence. These messages should be repeated at every opportunity. Appropriate patients should be offered pharmacologic assistance in quitting, such as nicotine replacement therapies, bupropion, and varenicline. Use of pharmacologic support during smoking cessation can double the rate of successful abstinence. Using more than one type of nicotine replacement therapy (

Tobacco, a legal product worldwide, killed 100 million people in the 20th century, and could kill as many as a billion human beings in the current century.1 Efforts to prevent tobacco-related morbidity and premature mortality depend on prevention programs, policies protecting people from tobacco smoke exposure, and effective cessation programs. Over a decade ago, Peto and Lopez showed that cessation will contribute quickly to lowering the burden of smoking-induced disease, because of the immediate health benefits of quitting and the long lag time for the development of many smoking-related diseases.2 Cessation has the additional benefit of the prevention of exposure of others to tobacco smoke. Yet, cessation for many smokers remains an elusive goal,3(p.15) with most quitters returning to their habit over time.4. Principles of behavior assume that the provision of knowledge works to change behavior when motivation for change is present. Increased perception of risk has been shown to be associated ...

Quitting smoking is beneficial to health at any age, and cigarette smokers who quit before age 35 years have mortality rates similar to those who never smoked (1,2). From 1965 to 2010, the prevalence of cigarette smoking among adults in the United States decreased from 42.4% to 19.3%, in part because of an increase in the number who quit smoking (3). Since 2002, the number of former U.S. smokers has exceeded the number of current smokers (4). Mass media campaigns, increases in the prices of tobacco products, and smoke-free policies have been shown to increase smoking cessation (5,6). In addition, brief cessation advice by health-care providers; individual, group, and telephone counseling; and cessation medications are effective cessation treatments (5). To determine the prevalence of 1) current interest in quitting smoking, 2) successful recent smoking cessation, 3) recent use of cessation treatments, and 4) trends in quit attempts over a 10-year period, CDC analyzed data from the 2001--2010 ...

Data collected during the immediate perioperative period (defined as from the morning of surgery through POD 8) for the NWS, PSS, NSS, and NPS were analyzed using PROC MIXED (version 8.2 of the SAS System for Unix; SAS Institute Inc., Cary, NC). For these models, a first-order autoregressive structure was used to model the covariance of repeated measures within individuals. Because of a skewed distribution, the analysis of PSS was performed using the square root of PSS as the dependent variable. To supplement these analyses, groups were compared separately at each time point using the rank sum test for PSS and the two-sample t test for NWS, NSS, and NPS. The proportions of subjects reporting 7-day point-prevalence abstinence from smoking at 30 and 180 days after surgery were compared between groups using the chi-square test, and at each time point, the changes in smoking rate from baseline were compared between groups using the rank sum test. In all cases, subjects with missing abstinence ...

OBJECTIVE: To examine the extent to which recommendations in the national guidelines for the cessation of smoking are based on evidence from systematic reviews of controlled trials. DESIGN: Retrospective analysis of recommendations for the national guidelines for the cessation of smoking. MATERIALS: National guidelines in clinical practice on smoking cessation published in English. MAIN OUTCOME MEASURES: The type of evidence (systematic review of controlled trials, individual trials, other studies, expert opinion) used to support each recommendation. We also assessed whether a Cochrane systematic review was available and could have been used in formulating the recommendation. RESULTS: Four national smoking cessation guidelines (from Canada, New Zealand, the United Kingdom, and the United States) covering 105 recommendations were identified. An explicit evidence base for 100%, 89%, 68%, and 98% of recommendations, respectively, was detected, of which 60%, 56%, 59%, and 47% were based on systematic

Physicians have frequent opportunities to intervene with their smoking patients as approximately 70% of smokers see a physician each year.1 Even brief counselling by a physician significantly improves the rate of smoking cessation according to meta-analyses performed by the Tobacco Use and Dependence Guideline Panel and summarised as ask, advise, assist, and arrange follow-up in the Agency for Health Care Policy and Research (AHCPR) guidelines.2 Despite these evidence based recommendations, physicians identify only about half of current smokers, advise less than half, and assist and arrange follow up with a small minority.3 There are several explanations for this disparity between physicians knowledge and their actual behaviour including inadequate training, resource and time constraints, and lack of information on community cessation resources.. Office systems that screen patients for smoking status increase the rate of smoking cessation interventions by health care providers.4 We ...

The effects of preoperative smoking cessation on the healing of fractures and postoperative complications: A systematic review and meta-analysis, Wei Min, Rongze An, Songjun Li, Ji

Once youve decided to quit smoking, set your target quit date a few weeks away. In the time leading up to your quit day, try some of these ideas offered by the Tobacco Control Research Branch of the National Cancer Institute to help you successfully quit smoking.. For the best results, work with your doctor. Together, you can test your lung function and compare the results to those of a nonsmoking person. The results can be given to you as your lung age. Finding out your lung age right after having the test done may help you to stop smoking.. Your doctor can also discuss with you all of your options and refer you to smoking-cessation support groups. You may wish to use nicotine replacement (gum, patches, inhaler) or one of the prescription medications that have been shown to increase quit rates and prolong abstinence from smoking. But whatever you and your doctor decide on these matters, it will still be you who decides when an how to quit. Here are some techniques: ...

The Duke-UNC Tobacco Treatment Specialist Training Program is a unique collaboration of three leaders in tobacco treatment, education, and research: the Duke Smoking Cessation Program, the University of North Carolina Tobacco Treatment Program an...

Tobacco use causes over 440,000 premature deaths each year in the United States and is the single most preventable cause of death and disease (CDC, 2002). Tobacco use is a risk factor for many types of cancer, heart disease, chronic pulmonary disease, and stroke. Health costs associated with tobacco use have created an economic health burden of more than 50 billion dollars. Although nationally the current cigarette smoking prevalence is 25% for men and 21 % for women, in rural areas adults and adolescents continue to exceed these percentages. As nurse practitioners can play an instrumental role in maintaining the health of rural residents, the Transtheoretical Model (TTM) can be used as a valuable and practical tool to evaluate the patients readiness for change and help facilitate interventions in assisting patients in rural communities with smoking cessation ...

SSTAR offers a number of smoking cessation services that include individual and group counseling. In addition, SSTAR offers tobacco treatment to local businesses who are interested in running a program for their employees.. A smoking cessation group is offered on Tuesday mornings at 10:30 A.M. The group focuses on education about nicotine dependence and provides a forum to learn coping skills to help with quit efforts. Any person at any stage of readiness who wants to look at their smoking behavior and discuss potential for quitting is welcome. The Mass. Bureau of Substance Abuse is supplying free nicotine patches and gum to assist with quit efforts. However, use of this tool is not required. If youd like to attend this group, visit our Open Access Center at 386 Stanley Street Fall River, MA 02720 between 7:30 AM and 3:00 PM, Monday through Friday, for an intake. Let them know of your interest in smoking cessation.. Individual counseling: Since individual needs vary, you may prefer a one on one ...

However, when looking at the details, one realizes that abrupt cessation is not what one generally would expect: Complete cessation on the target quit date and immediate initiation of NRT, as generally recommended in the package inserts of such therapy. This was not done. The abrupt strategy in this trial was less abrupt and more prepared than it may seem ...

Head Office National Addiction Centre, P048 Institute of Psychiatry, Psychology and Neuroscience, 4 Windsor Walk, London, SE5 8AF, UK ...

These two studies demonstrate, for the first time, that it is feasible to recruit pregnant smokers to exercise-based smoking cessation programmes. Our recruits were generally positive about both programmes, although the hospital-based scheme was viewed more positively than the programme delivered in womens homes. One quarter of the women recruited to either of the programmes quit smoking to the end of pregnancy, a rate which is similar to that shown for NRT in non-pregnant smokers [16]. However, this may be an optimistic estimate of the expected smoking cessation rates because we verified abstinence by expired CO rather than by a more reliable measure such as cotinine [50]. Moreover, the study did not include a control condition and quit rates might have been higher than usual had a control condition been used because these women were interested in increasing physical activity and therefore may have been more health conscious and more motivated to stop smoking than usual.. The proportion of ...

The great majority of smokers are chronically dependent on tobacco. This dependence arises from the rituals and sensory associations of smoking that are reinforced, within seconds, by a rapid burst of nicotine from the cigarette. All forms of nicotine replacement therapy (NRT) - gum, patches and inhaler - and bupropion are safe and effective for increasing smoking cessation rates in the short and long terms. Other than those who are minimally dependent, all patients willing to quit should be offered one of these therapies unless contraindications exist. The effectiveness of drug treatments is multiplied when associated with effective counseling or behavioral treatments. While NRT is not recommended during pregnancy or in patients with cardiac disease, if the alternative is smoking NRT is almost certainly safe. Combination NRT (more than one therapy) may be indicated in patients who have failed monotherapy in association with withdrawal symptoms. There are some specific contraindications to the ...

PURPOSE : To evaluate the effects of randomly assigning smokers who have early chronic obstructive pulmonary disease COPD to a smoking-cessation intervention on the symptoms of chronic cough, chronic phlegm production, wheezing and shortness of breath, and to determine the effects of quitting smoking on these symptoms. SUBJECTS AND METHODS : A...

Longtime women smokers are two-and-a-half times more likely to suffer sudden cardiac death than non-smokers, a researcher in Canada says.

The Tobacco Prevention and Education Program (TPEP) is a local Lead Agency coordinating tobacco control efforts in Solano County since 1990. TPEP is a program of the Health Promotion and Community Wellness Bureau within Solano Public Health. TPEP focuses on these major areas ...

MAIN RESULTS: We found 40 RCTs meeting inclusion criteria in total (21 trials were new in this update, 5 new trials contributed to long-term results (more than 12 months)). Interventions consist of behavioural therapeutic approaches, telephone support and self-help material and were either focused on smoking cessation alone or addressed several risk factors (eg. obesity, inactivity and smoking). The trials mostly included older male patients with CHD, predominantly myocardial infarction (MI). After an initial selection of studies three trials with implausible large effects of RR , 5 which contributed to substantial heterogeneity were excluded. Overall there was a positive effect of interventions on abstinence after 6 to 12 months (risk ratio (RR) 1.22, 95% confidence interval (CI) 1.13 to 1.32, I² 54%; abstinence rate treatment group = 46%, abstinence rate control group 37.4%), but heterogeneity between trials was substantial. Studies with validated assessment of smoking status at follow-up had ...

Scope NCI launches smoking cessation support for teens HealthCanal.com By connecting with teen smokers on their mobile phones, NCI hopes to more effectively engage young people in quitting with proven

Authors: Fagan P, Shavers V, Lawrence D, Gibson JT, Ponder P. Title: Cigarette smoking and quitting behaviors among unemployed adults in the United States.. Journal: Nicotine Tob Res 9(2):241-8. Date: 2007 Feb. Abstract: Little is known about factors associated with smoking among the unemployed. This study estimated the prevalence of smoking and examined sociodemographic factors associated with current, former, and successful quitting among unemployed adults aged 18-64. Cross-sectional data on 13,480 participants in the 1998-1999 and 2001-2002 Tobacco Use Supplements to the Current Population Surveys were analyzed. Multivariate logistic regression analyses were used to examine factors associated with study outcomes (current vs. never, former vs. current, successful quitter vs. other former smoker). Among the unemployed, 35% were current smokers and 13% were former smokers. Of the former smokers, 81% quit successfully for at least 12 months. Participants with family incomes of less than US$25,000 ...

TY - JOUR. T1 - Review and evaluation of online tobacco dependence treatment training programs for health care practitioners. AU - Selby, Peter. AU - Goncharenko, Karina. AU - Barker, Megan. AU - Fahim, Myra. AU - Timothy, Valerie. AU - Dragonetti, Rosa. AU - Kemper, Katherine. AU - Herie, Marilyn. AU - Hays, J. Taylor. N1 - Publisher Copyright: ©Peter Selby, Karina Goncharenko, Megan Barker, Myra Fahim, Valerie Timothy, Rosa Dragonetti, Katherine Kemper, Marilyn Herie, J Taylor Hays.. PY - 2015/4/1. Y1 - 2015/4/1. N2 - Background: Training health care professionals is associated with increased capacity to deliver evidence-based smoking cessation interventions and increased quit rates among their patients. Online training programs hold promise to provide training but questions remain regarding the quality and usability of available programs. Objective: The aim was to assess the quality of English-language online courses in tobacco dependence treatment using a validated instrument. Methods: An ...

This page provides useful content and local businesses that can help with your search for Tobacco Cessation Programs. You will find helpful, informative articles about Tobacco Cessation Programs, including Tobacco Cessation. You will also find local businesses that provide the products or services that you are looking for. Please scroll down to find the local resources in Rockmart, GA that will answer all of your questions about Tobacco Cessation Programs.

Looking for online definition of Smoking-Cessation Drugs in the Medical Dictionary? Smoking-Cessation Drugs explanation free. What is Smoking-Cessation Drugs? Meaning of Smoking-Cessation Drugs medical term. What does Smoking-Cessation Drugs mean?

Methods New patients at the UACC are contacted by a member of the ONN team and asked about tobacco use and history during the ONN New Patient Barriers to Care and Psychosocial Assessment. If a patient identifies as a tobacco user, the ONN delivers a brief intervention and provides a referral to the REACCH program tobacco treatment specialist (TTS) through the EHR. The TTS offers evidence-based strategies for quitting and develops an individualized tobacco dependence treatment plan, which may include education material, NRT, and in-person or telephone-based coaching with repeated follow-up. Metrics include program utilization and effectiveness, including assessment of tobacco use for all patients per the NCI definition of a smoker and 7-day point prevalence of tobacco use at 6-month follow-up.. Results Since the launch of the REACCH program on January 1, 2019, 774 new patients have been screened for tobacco use. Of these, 114 patients have identified as tobacco users. The majority of patients ...

Behavioural and pharmacological treatment for tobacco dependence typically lasts 6-12 weeks. Unfortunately, the majority of smokers relapse within 3 months of treatment. Abstinence rates at the end of treatment are consistently approximately double long-term abstinence rates (6 or 12 months after quit date and off medication), so there is considerable interest in whether we stop pharmacological treatment prematurely and whether prolonged treatment might increase long-term abstinence.. ...

Study Title: Integrated PTSD and Smoking Treatment. Sponsor: National Institute on Drug Abuse. Objective: Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD. One option is to give patients standard smoking cessation treatment including nicotine replacement and cognitive behavioral therapy. Another option is to give patients the standard smoking cessation treatment in addition to treatment for their PTSD symptoms (called prolonged exposure). However, it is not known which method works better. In order to answer this question, patients will be assigned by chance to one of two groups. One group will be given standard smoking cessation treatment to help quit smoking. A second group will be given the standard smoking cessation intervention to help quit smoking in addition to a ...

Milan C Mathew Memorial Hospital of Rhode Island/Brown University March 9, 2005 The Effects of Smoking Cessation Intervention on Mortality: The Interventions I read with great interest the article by Anthonisen et.al., regarding the effects of a smoking cessation intervention on 14.5 year mortality in the Lung Health Study. The authors conclude that smoking cessation intervention programs can have a substantial effect on subsequent mortality, even when successful in a minority of participants. The generalizability of the study results being potentially limited to heavy smokers with pre-existing airway obstruction. The study provides convincing evidence that smoking cessation lowers all-cause mortality. The mortality experience between the two study groups, the usual care group and special intervention group, did not differ significantly between those with similar smoking habits and hence the decrease in mortality is attributable to differential cessation rates between the two study ...

More than 90% of dental providers reported that they routinely ask patients about tobacco use, 76% counsel patients, and 45% routinely offer cessation assistance, defined as referring patients for cessation counseling, providing a cessation prescription, or both. Results from multivariable analysis indicated that cessation assistance was associated with having a practice with 1 or more hygienists, having a chart system that includes a tobacco use question, having received training on treating tobacco dependence, and having positive attitudes toward treating tobacco use. Providers who did not offer assistance but who reported that they would change their practice patterns if sufficiently reimbursed were more likely to be in a group practice, treat patients insured through Medicaid, and have positive attitudes toward treating tobacco dependence ...

PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.

The University of South Alabama encourages all employees to adopt healthy lifestyle choices. That effort will benefit you, your family and your fellow employees. The Universitys Fringe Benefits Committee recommended, and the University adopted, a tobacco cessation program which is intended to help employees stop using tobacco products. Tobacco use and especially smoking will increase your risk of heart disease, stroke, respiratory diseases such as emphysema and bronchitis, as well as cancer including: lung, throat, mouth, esophagus, pancreas, bladder, and leukemia. The benefits from stopping the use of tobacco are almost immediate regardless of how long you have been smoking or using tobacco. Employees who declare, on the Tobacco Declaration form, that they and their covered spouse do not use tobacco products; and have not used tobacco products within six months, prior to the date on the form, will qualify for a wellness incentive of $50 per month (one per family). The wellness incentive will ...

It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key to reducing smoking-related diseases and deaths. Healthcare providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible healthcare providers and are uniquely situated to initiate behavior change among patients. Many studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist-delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar. A prospective, randomized, controlled trial is conducted at eight ambulatory pharmacies in Qatar. Participants are randomly assigned to receive an at least four-session face-to

Thomas Land and colleagues show that among Massachusetts Medicaid subscribers, use of a comprehensive tobacco cessation pharmacotherapy benefit was followed by a substantial decrease in claims for hospitalizations for acute myocardial infarction and acute coronary heart disease.

As the leading respiratory hospital in the U.S., National Jewish Health® has developed a tobacco cessation program that empowers people to overcome their addiction.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. (2010)Tobacco use is the leading cause of preventable death and disability in the world. Although gradually declining in most developed countries, the prevalence of tobacco use has increased among developing countries. Treatment for tobacco use and dependence is effective, although long-term abstinence rates remain disappointingly low. In response, new treatments continue to be developed. In addition, many of the pharmacotherapies that have been available for years have found new applications with the use of medication combinations, higher doses and a longer duration of therapy for approved medications. There are now seven medications (nicotine patch, nicotine gum, nicotine lozenge, nicotine inhaler, nicotine nasal spray, bupropion sustained release and varenicline) approved for tobacco dependence treatment in most countries, and many national and professional society practice guidelines recommend ...

This study randomized quitline callers in New Zealand to usual quitline care including reduced cost for their choice of NRT (control), or receipt of a box containing different NRT products to try for a week prior to quitting (experiment). Participants in the experimental arm could then select one or two types of NRT to use for eight weeks. No differences in six-month 7-day point prevalence or continuous abstinence quit rates were found between the groups. However, experimental arm participants were more likely to have quit at three months, had a longer time to relapse, and used more NRT than their control arm counterparts. The study authors conclude that a period of familiarization with NRT products did not contributed to higher quit rates at 6 months ...

For those looking to stop smoking, the Center for Community Health & Prevention team of physicians, nurse practitioners and lifestyle offers individualized tobacco dependent treatment counseling.

Overview. This project is a partnership between the MPHCA and the MS State Department of Health Office of Tobacco Control (OTC). Program funding and support is provided by OTC. The OTC mission is to promote and protect the health of all Mississippians by reducing tobacco-related disease and death. OTC program components include: 1) State & Community Interventions, 2) Tobacco Cessation Interventions, 3) Health Communication Interventions, and 4) Surveillance & Evaluation. The Purpose of the Tobacco-Free project is to strengthen statewide capacity to conduct clinical tobacco cessation programs and activities. A fundamental philosophy is that people are more likely to follow through with advice to cease tobacco use when it comes from a healthcare provider. Statistics of Need (from MSDH/OTC). ...

Summarizes the results of a study on the feasibility of integrating tobacco treatment and support within mental health, addictions and sexual violence services, in a gender informed way. The study included focus groups with service providers and with smokers, and a review of the literature on tobacco cessation in the mental health, substance use, and trauma treatment fields. Found that smokers who use mental health, substance use, and sexual violence services are generally knowledgeable about the harms of smoking, and the majority are interested in quitting.. ...

Objective: To assess tobacco use, attitudes and cessation practices among healthcare workers of a municipal health department in southern India. Materials and Methods: We undertook a cross-sectional epidemiologic study to investigate 558 healthcare workers from three groups (doctors, auxiliary nurses and community link workers (LWs)) employed by the Bangalore city corporation in southern India.

TY - JOUR. T1 - Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. AU - Leventhal, A. M.. AU - David, S. P.. AU - Brightman, M.. AU - Strong, D.. AU - McGeary, J. E.. AU - Brown, R. A.. AU - Lloyd-Richardson, E. E.. AU - Munafò, M.. AU - Uhl, G. R.. AU - Niaura, R.. N1 - Funding Information: This research was supported by NIH grants DA025041 (AML), HL32318 and CA84719 (RN), DA08511 (RAB), DA14276 and DA27331 (SPD) and NIDA-IRP.. PY - 2012/2. Y1 - 2012/2. N2 - Smokers (10 cigarettes per day, N331) of European ancestry taking part in a double-blind placebo-controlled randomized trial of 12 weeks of treatment with bupropion along with counseling for smoking cessation were genotyped for a variable number of tandem repeats polymorphism in exon III of the dopamine D4 receptor gene. Generalized estimating equations predicting point-prevalence abstinence at end of treatment and 2, 6 and 12 months after the end of treatment indicated that bupropion (vs ...

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the August 2006 basic CPS questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in May 2006 (ICPSR 24781) and January 2007 (ICPSR 24783). These three supplements comprise the 2006-2007 waves of TUS data.The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. ...

Smoking in pregnancy is a public health problem. Self-help smoking cessation support can help pregnant women to stop smoking, but the effects of delivering this kind of support via SMS text message are not known. A previous randomised controlled trial (RCT) demonstrated the feasibility and acceptability of providing such support to pregnant smokers using an automated, tailored text message intervention called MiQuit. This larger RCT will estimate key parameters for and will test the feasibility of delivering a major trial run within the United Kingdom National Health Service settings aimed at providing definitive evidence on the utility of MiQuit for helping pregnant smokers to stop. This will be a multi-centre, parallel group RCT. Participants are being identified in 16 English antenatal care settings and must be |16 years old, pregnant, |25 weeks gestation, smoke |1 daily cigarette, have smoked |5 daily cigarettes before pregnancy, and able to understand texts in English. After consenting and the

In this lesson, you will learn about the pharmacotherapy for smoking cessation. Many people know that smoking is bad for them. Yet, smoking remains the leading cause of preventable death worldwide. Its also interesting to note that less than one-third of smokers who tried to quit used proven smoking cessation treatments. So why arent people utilizing treatment? One reason could be that health care providers are not engaging in smoking cessation efforts. Lets take a vote. The most common reason for lack of engagement is, lack of time, lack of expertise, or belief that efforts wont help. Sadly, time, knowledge and belief are all barriers. The good news is by the end of this lesson, you will see that it does not take that much time or know-how to recommend medications. Remember that rates of successfully quitting nearly double with the use of medications. So lets get started. We have seven FDA-approved medications for smoking cessation, including nicotine replacement therapies, or NRTs, ...

Smoking Cessation - Data, Analysis & Forecasts till 2023 Pharmaceutical, Commercial & Strategic Developments in the Global Smoking Cessation Market 2013-2023. In April 2013 the US Food & Drug Agency (FDA) announced its plan to relax rules regarding the use and labelling of over-the-counter nicotine replacement therapies.. Browse Detail Report With TOC @ http://www.researchmoz.us/smoking-cessation-data-analysis-and-forecasts-to-2023-report.html. On April 1st 2013, FDA Commissioner Margaret A. Hamburg M.D. stated, The agency heard from several public health groups that the labelling for OTC NRT products may stop consumers who are trying to quit smoking from using them. The FDA hopes the recommended changes will allow more people to use these products effectively for smoking cessation and that tobacco dependence will decline in this country. Will new changes increase take-up of smoking cessation products? This report tells you ...

The details of bibliography - Identifying multi-level culturally appropriate smoking cessation strategies for Aboriginal health staff: a concept mapping approach

TY - JOUR. T1 - Smoking cessation and weight gain. AU - LEISCHOW, SCOTT J.. AU - STITZER, MAXINE L.. PY - 1991/5. Y1 - 1991/5. N2 - Significant progress has been made in the research on smoking cessation and weight gain since the 1988 Surgeon Generals Report, particularly on mechanisms and treatment methods. Smoking cessation results in weight gain in most quitters, primarily due to changes in caloric intake and to a lesser extent from changes in energy expenditure. Thus far, pharmacologic treatments appear more efficacious at preventing the weight gain than behavioral methods. And regarding who should receive treatment, preliminary research suggests that females are more concerned about postcessation weight gain than males, and it is the concern about weight gain‐more than the weight gain itself‐that appears to play an important role in relapse to smoking. Given the progress that has been made along the spectrum from mechanisms to treatment, those concerned about postcessation weight now ...

TY - JOUR. T1 - Smoking cessation and weight gain. AU - Leischow, S. J.. AU - Stitzer, M. L.. PY - 1991. Y1 - 1991. N2 - Significant progress has been made in the research on smoking cessation and weight gain since the 1988 Surgeon Generals Report, particularly on mechanisms and treatment methods. Smoking cessation results in weight gain in most quitters, primarily due to changes in caloric intake and to a lesser extent from changes in energy expenditure. Thus far, pharmacologic treatments appear more efficacious at preventing the weight gain than behavioral methods. And regarding who should receive treatment, preliminary research suggests that females are more concerned about postcessation weight gain than males, and it is the concern about weight gain - more than the weight gain itself - that appears to play an important role in relapse to smoking. Given the progress that has been made along the spectrum from mechanisms to treatment, those concerned about postcessation weight now have ...

People with mental health and addictive (MHA) disorders smoke at high rates and require tobacco treatment as a part of their comprehensive psychiatric care. Psychiatric care providers often do not address tobacco use among people with mental illness, possibly owing to the belief that their patients will not be able to quit successfully or that even short-term abstinence will adversely influence psychiatric status. Progress in the development of treatments has been slow in part because smokers with current MHA disorders have been excluded from most smoking cessation trials. There are several smoking cessation treatment options, including psychological and pharmacological interventions, that should be offered to people with an MHA disorder who smoke. Building motivation and readiness to quit smoking is a major challenge, and therefore motivational interventions are essential. We review the treatment options for people with tobacco dependence and MHA disorders, offer recommendations on tobacco ...

Newly published research suggests that combination treatments for smoking cessation can assist individuals who were not helped by one treatment alone, and that men and highly nicotine-dependent smokers tend to benefit most from the combination therapies.. Published online today in the American Journal of Psychiatry, the findings were derived from a study of nearly 350 adults who smoked more than 10 cigarettes a day. All subjects received a nicotine patch for a week, and those who were not able to reduce their smoking by 50% then received varenicline and a placebo or varenicline and bupropion for 12 weeks. The group receiving varenicline and bupropion had the best outcomes, with just under 40% abstaining from smoking at weeks 8 to 11 after their target quit date.. Its clear that we need to improve success rates for smoking cessation, and it is thought that combining treatments could add to the efficacy, said Jed Rose, PhD, director of the Duke Center for Smoking Cessation and the studys lead ...

colleagues, including Ross Prentice, PhD, one of the Principal Investigators of the Womens Health Initiative. They studied smoking patterns and smoking-related deaths over a 50 year period, using data from five large studies, including the Womens Health Initiative. In total, the study included more than 2.2 million adults 55 years and older; of those, 156,701 were WHI participants who provided updated information on smoking in 2000.. This increased risk of dying from smoking-related diseases reflects the change in womens smoking habits. Compared with women in previous generations, women smokers today smoke more like men, that is, they start earlier in adolescence and until recently, smoke more cigarettes per day (smoking peaked in the 1980s). These findings strongly confirm the prediction that if women smoke like men, they will die like men.. For women who smoked in the 1960s, the risk of dying from lung cancer was 2.7 times higher than it was for women who had never smoked. In the cohort ...

Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439.. Baker TB, Piper ME, Stein JH, et al. Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial. JAMA. 2016 Jan 26;315(4):371-9. PMID: 26813210 www.ncbi.nlm.nih.gov/pubmed/26813210.. Berlin I, Grangé G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ. 2014 Mar 11;348:g1622. PMID: 24627552 www.ncbi.nlm.nih.gov/pubmed/24627552.. Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014 Oct 14;130(16):1418-36. Epub 2014 Aug 24. PMID: 25156991 www.ncbi.nlm.nih.gov/pubmed/25156991. Brion MJ, Victoria C, Matijasevich A, et al. Maternal smoking and child psychological problems: disentangling causal and noncausal effects. ...

Women smokers may not be at greater risk for lung cancer than their male counterparts. These results were recently published in Lancet Oncology.. Lung cancer claims more lives every year than any other type of cancer. In fact, lung cancer kills more people than breast cancer, colon cancer, and prostate cancer combined. It is well known that smoking is associated with a significantly increased risk of developing lung cancer. However, there has been recent debate as to whether female smokers are more susceptible to developing lung cancer than male smokers.. To further explore the possible association between gender, smoking, and lung cancer risk, researchers from the National Institutes of Health analyzed data from a questionnaire sent to participants of the NIH-AARP Diet and Health study. Participants responded to the questionnaire between 1995 and 1996 and were followed through the end of 2003. The data included nearly 280,000 men and approximately 186,000 women.. Among smokers the incidence of ...

MD Anderson News Release 02/01/2011. No-cost multimedia site gets a language makeover. MD Anderson News Release 02/01/11. HOUSTON - The University of Texas MD Anderson Cancer Center's popular web-based teen prevention and smoking-cessation program, ASPIRE (A Smoking Prevention Interactive Experience), now speaks Spanish.. The 10-year-old program advances the institution's national commitment to help prevent teens from smoking or help them quit before it becomes a lifelong addiction. ASPIRE is an evidence-based tobacco prevention and cessation website for middle and high school students. It was developed by a research team led by Alexander V. Prokhorov, M.D., Ph.D., a professor in the Department of Behavioral Science at MD Anderson. The site integrates interactive media, customized messages, graphics, animations and streaming videos.. The potential number of youth this program has the ability to reach and educate on the dangers of smoking is phenomenal, said Prokhorov.. We've ...

Suffolk lawmakers criticized a cut proposed in Suffolk County Executive Steve Bellones budget to end a tobacco cessation program, saying it could lead to higher smoking rates and health care costs.Th

Welcome to Qatar University, the first, largest, and most prominent institution for higher education in Qatar. This website is dedicated to providing information on the numerous Academic Programs, Employment Openings, and Research Opportunities available at QU. With over 8000 students, 700 faculty members, and the countrys widest selection of programs and majors, were proud to offer the best education, research support and set of industrial opportunities that the region has to offer.

In terms of exercise interventions in combination with smoking cessation, a project of the group of sport psychology focus on exercise as an add-on therapy in smoking cessation in people with mental illness. Smoking is the most common substance abuse in individuals with mental disorders. The prevalence rates for people with mental illness are two to four times higher than in the general population. In contrast to a decrease in smoking in healthy individuals, the number of smokers with mental disorders doesnt decrease. Unsuccessful attempts to quit smoking, low levels of confidence in their ability to quit and more focus of smoking cessation efforts on the general population indicate that smokers with mental illness may benefit from additional strategies for quitting.. As part of the project, a randomized controlled clinical trial in collaboration with the Department of Psychiatry, Psychotherapy and Psychosomatics of the Medical University of Innsbruck is conducted. People with mental illness ...

We performed a follow up study about willingness and behaviors to quit smoking among smokers with schizophrenia in Japan. Participants were outpatients with schizophrenia aged 20-69 years who had been visiting the hospital for ≥1 year as of April 1, 2016, and had visited the hospital more than once in the previous 6 months. A baseline survey on smoking behaviors including current smoking status and smoking cessation stage, was administered in 420 participants that were randomly extracted from a patient pool (n = 680) in 2016, and a follow-up survey was administered in 2017. We calculated the distribution and change in smoking cessation stage, number of smokers and nonsmokers after 1 year, and quitting rate from a naturalistic 1-year smoking-cessation follow up. The number of baseline respondents was 350; 113 current smokers and 68 former smokers. Among the 113 current smokers, 104 (92.0%) were followed for 1 year, 79 (70.0%) were interested in smoking cessation, and only 7 had received smoking

IN addition to its detrimental effects on long-term health, cigarette smoking by surgical patients increases the risk of perioperative complications, such as wound infections and pneumonia, in addition to its detrimental effects on long-term health.1 Surgery represents a teachable moment for smoking cessation (i.e. , an event that motivates individuals to adopt health behaviors that reduce risk),2,3 and there are many opportunities for clinicians who provide surgical care to deliver tobacco interventions to their patients.4 A US Public Health Service clinical practice guideline on tobacco use and dependence5 urges that all smokers who come in contact with the health care system receive tobacco intervention as an integral part of their routine clinical care. The guideline recommends an evidence-based technique codified as the 5As approach: A sk about tobacco use, A dvise them to quit, A ssess willingness to quit, A ssist quitting attempts, and A rrange for follow-up. However, some of the ...